Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
¶ … buy Bristol Squib Meyers stock today? Why?
Investing the pharmaceutical industry is always a dicey prospect. Although the drug industry has the advantage that many of its customers cannot opt out of buying its product, there are also many disadvantages to buying pharmaceutical stocks. First of all, drug patents are finite, which means that even a successful drug is likely to have a short life of generating a great deal of money for the company, as was seen with Pfizer's Prozac. The new type of antidepressant eventually spawned many spin-offs from Pfizer's competitors, as well as a generic version. The same thing is likely to happen to Glucophage, now that its patent has ended. Also, a company can spend a great deal of money on a new drug's development, only for the drug to fall flat in terms of its effectiveness, as was seen in the case of Erbitux.
In today's litigious environment, there are more concerns about drug's side effects and the ethics of pharmaceutical advertising of new treatments to consumers. Even if Bristol-Squib Meyers is not directly implicated in all of the cases surrounding this issue, fears about the over all health of the industry will affect stock prices. And finally, there is increased consumer outrage about drug costs and pressure to change current regulations about providing effective health care to Americans. Whatever the long-term impact upon the industry, the government is likely to have to devote considerable resources to health care reform in the near future. Changes in regulation, whatever they are, will make pharmaceutical stocks very volatile for the next 5-7 years.
Finally, the particularly negative publicity surrounding ImClone, justified or not, will negatively impact stock prices for all of the companies connected to the scandal, and Bristol must struggle and devote valuable corporate resources to generate positive media coverage to regain its faltering ethical reputation in the eyes of investors and consumers.
Stock Price Trading Value and Stock Price relationship between trading volume and price In their 2005 article, Gunduz and Hatemi-J have explored the relationship between stock price and volume by using information from the major stock markets of Central and Eastern Europe. They have made use of the Toda-Yamamoto (1995) procedure to determine Granger causality among the variables. The findings of their study provide insight into the different ways stock price and volume
Microsoft Corporation 2. Toyota Motor Corp. 3. The Coca-Cola Company The data in the Table 2 reveals the Coca Cola has recorded a decline in its stock price within the last 3 months making investors to record a loss within the last three months. However, the company recorded a moderate increase in the stock returns between 1 and 5 years. Similarly, Microsoft Corporation records a decline in the stock price within the
In these scenarios, stock options provide a powerful tool in which to properly align the goals of management with those of the firm What exactly performance-oriented rewards are in regards stock options? To begin, options are not stock in its physical form but rather a claim to stock at a predetermined price. There are two key distinctions regarding this concept. First, stock options have an asymmetric payoff (see Chapter 2)
Stock Market Prices and the Media During the Tech Bubble Stock Price and the Media During the Tech Stock Bubble The world of stock trading at first gives the impression of a hardcore science. Prediction of stock movement is based on a complex series of formulas, algorithms, and mathematical predictive models. These portions of stock trading represent the quantitative element of the stock world. However, there is also a qualitative side to
Stock/Equity Qs How good is the long-run performance of IPO firms? How is holding on to IPO stocks is a risky proposition? Explain. All publicly traded companies have some form of initial public offerings, and thus judging the truly long-term performance of IPO value means assessing stock market value. In shorter terms, however, most IPO purchases end up lagging behind market averages, and ultimately many newer companies fail (Goldberg, 1999). This means
Stock Options Payment of stratospheric compensations to the corporate executives by the dot.com companies is the talk of the day. It is pertinent to note that these compensations are paid not only in terms of the cash compensations but also in terms of stock options. However, compensations plans in terms of stock options are not new and being used years together in order to attract the employees and retain with a